DDR2 and carcinoma: To the best of our knowledge, this is the first study that comprehensively examined the significance of DDR2 and collagen type I. When we immunolocalized DDR2 and collagen type I in 224 human breast cancer tissues, their immunoreactivity was significantly increased in carcinoma cells or cancerous stroma compared to normal breast epithelium or stroma.